iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
- WOBURN, Mass., Oct. 30, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the pricing of its public offering of approximately $5 million of the Company's common stock, and/or pre-funded warrants to purchase shares of common stock at a public offering price of $3.00 per share (minus $0.0001 per pre-funded warrant). The Company intends to use the proceeds of the offering for repayment of outstanding debt, potential acquisitions of assets or investments in businesses, products and technologies and for marketing and advertising services. The remainder of proceeds will be used for working capital purposes.
- 10/30/2024
|
iSpecimen Secures $1 Million Loan; Appoints Three New Board Members
- WOBURN, Mass., Sept. 26, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it has secured a $1 million loan agreement and subsequently appointed three new members to its Board of Directors.
- 09/26/2024
|
iSpecimen Announces 1-for-20 Reverse Stock Split
- WOBURN, Mass., Sept. 11, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it will effect a reverse stock split of its issued and outstanding shares of common stock, par value $0.0001 per share, as well as any shares of common stock held by the Company in treasury, at a ratio of 1-for-20. The reverse stock split will become effective at 4:30 p.m. Eastern Time on September 13, 2024, and the Company's common stock will begin trading on a split-adjusted basis when the market opens on September 16, 2024. The Company's common stock will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol "ISPC." The new CUSIP number for the Company's common stock following the reverse stock split will be 45032V207.
- 09/11/2024
|
iSpecimen Inc. (ISPC) Q2 2024 Earnings Call Transcript
- iSpecimen Inc. (NASDAQ:ISPC ) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Phil Carlson - IR, KCSA Strategic Communications Tracy Curley - CEO and CFO Leslie Hoyt - VP, Operations Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Operator Good morning everyone and welcome to the iSpecimen Second Quarter 2024 Earnings Conference Call. At this time, participants are in a listen-only mode.
- 08/10/2024
|
iSpecimen Reports Second Quarter 2024 Results
- Revenue increased 76% year-over-year to approximately $2.86 million Brielan Smiechowski Named SVP of Sales and Business Development LEXINGTON, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three and six month periods ended June 30, 2024.
- 08/06/2024
|
iSpecimen Inc. (ISPC) Q1 2024 Earnings Call Transcript
- iSpecimen Inc. (NASDAQ:ISPC ) Q1 2024 Earnings Conference Call May 7, 2024 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCSA Strategic Communications Tracy Curley - Chief Executive Officer & Chief Financial Officer Leslie Hoyt - Senior Vice President of Operations Conference Call Participants Matt Hewitt - Craig Hallum Capital Operator Good day everyone and welcome to iSpecimen's First Quarter 2024 Results Conference Call. [Operator Instructions] This conference call is being recorded.
- 05/12/2024
|
iSpecimen Reports First Quarter 2024 Results
- LEXINGTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three-month period ended March 31, 2024.
- 05/07/2024
|
iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024
- LEXINGTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the first quarter of 2024 ended March 31, 2024 before the market opens on Tuesday, May 7, 2024.
- 04/25/2024
|
iSpecimen Reports Full Year 2023 Results
- LEXINGTON, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the twelve-month period ended December 31, 2023.
- 03/14/2024
|
iSpecimen Reschedules Full Year 2023 Earnings Release and Conference Call
- The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern The Company will now report results after the market closes on March 13, 2024 and reschedules conference call to Thursday, March 14, 2024 at 8:30am Eastern
- 03/12/2024
|
iSpecimen to Report Full Year 2023 Financial Results on March 13, 2024
- LEXINGTON, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the full year ended December 31, 2023 before the market opens on Wednesday, March 13, 2024.
- 03/05/2024
|
iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based Research
- Partnership Aims to Optimize Quality Control and Assurance Through Digital AI Histopathology Services Partnership Aims to Optimize Quality Control and Assurance Through Digital AI Histopathology Services
- 01/23/2024
|
iSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024
- LEXINGTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it will be participating in the Maxim Group Virtual Healthcare IT Conference on January 25, 2024. Tracy Curley, Chief Executive Officer, will present at 10:00 a.m. ET.
- 01/18/2024
|
iSpecimen Strengthens Global Oncology Biospecimen Offering
- Adds New Suppliers and Expands Existing Relationships to Provide Researchers Increased Access to Highly-Sought-After Biospecimens to Advance Oncology Research Adds New Suppliers and Expands Existing Relationships to Provide Researchers Increased Access to Highly-Sought-After Biospecimens to Advance Oncology Research
- 12/07/2023
|
iSpecimen Inc. (ISPC) Q3 2023 Earnings Call Transcript
- iSpecimen Inc. (NASDAQ:ISPC ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCSA Strategic Communications Tracy Curley - Chief Executive Officer and Chief Financial Officer Benjamin Bielak - Chief Information Officer Eric Langlois - Chief Revenue Officer Carly Lejnieks - Vice President of Marketing. Conference Call Participants Matt Hewitt - Craig Hallum Operator Good day, everyone, and welcome to iSpecimens Third Quarter 2020 Results Conference Call.
- 11/03/2023
|
iSpecimen Reports Third Quarter 2023 Financial and Operating Results
- Sequential Quarterly Revenue Growth of 75% Driven by Enhanced Operational Efficiencies of iSpecimen Marketplace and Rollout of New Business Initiatives Sequential Quarterly Revenue Growth of 75% Driven by Enhanced Operational Efficiencies of iSpecimen Marketplace and Rollout of New Business Initiatives
- 11/02/2023
|
iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research
- New Providers Facilitate Access to Diverse and Hard-to-Reach Populations and Support Complex Custom Projects New Providers Facilitate Access to Diverse and Hard-to-Reach Populations and Support Complex Custom Projects
- 10/26/2023
|
iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially
- Management to Host Third Quarter 2023 Conference Call on Thursday, November 2, 2023 Management to Host Third Quarter 2023 Conference Call on Thursday, November 2, 2023
- 10/23/2023
|
iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers
- Accurate Pricing Delivered Within 24 Hours to Enhance the Customer Journey and Accelerate Medical Research Accurate Pricing Delivered Within 24 Hours to Enhance the Customer Journey and Accelerate Medical Research
- 09/28/2023
|
iSpecimen Expands Provider Network to Enhance Support for Women's Health Research
- Additional Providers Increase Biospecimen Access for Researchers Focused on Cervical, Uterine and Breast Cancers, as well as Reproductive Health, Cardiovascular Disease, Autoimmune Disorders and STIs Additional Providers Increase Biospecimen Access for Researchers Focused on Cervical, Uterine and Breast Cancers, as well as Reproductive Health, Cardiovascular Disease, Autoimmune Disorders and STIs
- 09/13/2023
|
iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability
- Company to Focus on Core Revenue Drivers, New Revenue Growth Opportunities from Recently Launched Sequencing Procurement Program and Expense Reductions Company to Focus on Core Revenue Drivers, New Revenue Growth Opportunities from Recently Launched Sequencing Procurement Program and Expense Reductions
- 09/06/2023
|
iSpecimen Launches New Virtual Cancer Sequencing Procurement Program
- Program to Provide Cancer Researchers with Direct Access to Highly Sought Donor Tumor Tissue Samples Virtual Inventory Comprised of Formalin-Fixed, Paraffin-Embedded (FFPE) Samples Screened for Mutations LEXINGTON, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the launch of a new program that gives researchers consistent and direct access to mutation-characterized formalin-fixed, paraffin-embedded (“FFPE”) cancer tumor tissues, relieving a major bottleneck in cancer research.
- 08/30/2023
|
iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers
- New Capabilities Enable Platform to Efficiently Collect and Store Most Up-to-Date Data from Providers and Facilitate Automated, Instant Matchmaking for Researcher Requests New Capabilities Enable Platform to Efficiently Collect and Store Most Up-to-Date Data from Providers and Facilitate Automated, Instant Matchmaking for Researcher Requests
- 08/16/2023
|
iSpecimen Introduces New Marketplace Functionality to Streamline Access to Clinical Remnant Samples for Researchers
- Company Continues to Enhance the Biospecimen Procurement Process and Provide Increasingly Robust Specimen and Patient Data Company Continues to Enhance the Biospecimen Procurement Process and Provide Increasingly Robust Specimen and Patient Data
- 08/09/2023
|
iSpecimen Inc. (ISPC) Q2 2023 Earnings Call Transcript
- iSpecimen Inc. (NASDAQ:ISPC ) Q2 2023 Earnings Conference Call August 2, 2023 8:30 AM ET Company Participants Phil Carlson - Investor Relations, KCSA Strategic Communications Tracy Curley - Chief Executive Officer and Chief Financial Officer Eric Langlois - Chief Revenue Officer Evan Cox - Vice President of Product Management Conference Call Participants Operator Good day, everyone, and welcome to iSpecimen's Second Quarter 2023 Results Conference Call. At this time participants are in a listen-only mode.
- 08/05/2023
|
iSpecimen to Report Second Quarter 2023 Results on August 2, 2023
- LEXINGTON, Mass., July 25, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the second quarter ended June 30, 2023 before the market opens on Wednesday, August 2, 2023.
- 07/25/2023
|
iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on June 1, 2023
- LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Healthcare IT Virtual Conference hosted by Maxim Group LLC (“Maxim”) and M-Vest, a division of Maxim, on Thursday, June 1, 2023.
- 05/23/2023
|
iSpecimen Inc. (ISPC) Q1 2023 Earnings Call Transcript
- iSpecimen Inc. (NASDAQ:ISPC ) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Tracy Curley - Chief Executive Officer Benjamin Beilak - Chief Information Officer Eric Langlois - Chief Revenue Officer Conference Call Participants Matt Hewitt - Craig Hallum Capital Group Operator Good morning, and welcome to iSpecimen First Quarter 2023 Earnings Conference Call [Operator Instructions]. Please note that this event is being recorded.
- 05/06/2023
|
iSpecimen to Participate in the Aegis Virtual Conference on May 4, 2023
- LEXINGTON, Mass., April 24, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Aegis Conference to be held virtually on May 2-4, 2023.
- 04/24/2023
|
iSpecimen Inc. (ISPC) Q4 2022 Earnings Call Transcript
- iSpecimen Inc. (NASDAQ:ISPC ) Q4 2022 Earnings Call Transcript March 14, 2023 8:30 AM ET Company Participants Allison Soss - Investor Relations-KCSA Strategic Communications Tracy Curley - Chief Executive Officer Benjamin Bielak - Chief Information Officer Eric Langlois - Chief Revenue Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Allen Klee - Maxim Group Operator Good day, everyone and welcome to iSpecimen's Full Year 2022 Conference Call. At this time, participants will be in a listen-only mode.
- 03/14/2023
|
iSpecimen sees 4Q revenue rise by 28% as it focuses on its supplier network and fulfillment efficiency
- iSpecimen Inc said its revenue jumped 28% year-over-year in the fourth quarter as it made quick improvements to supplier utilization rates to boost overall fulfillment efficiency. For the period ended December 31, 2022, the Lexington, Massachusetts-based company reported revenue of $3.2 million, compared to $2.5 million in 4Q 2021.
- 03/14/2023
|
iSpecimen to Report Fourth Quarter and Full Year 2022 Results on March 14, 2023
- LEXINGTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2022, before the markets open on Tuesday, March 14, 2023.
- 02/28/2023
|
iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on January 25, 2023
- LEXINGTON, Mass., Jan. 19, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Healthcare IT Virtual Conference hosted by Maxim Group and M-Vest on Wednesday, January 25, 2023.
- 01/19/2023
|
iSpecimen Inc. (ISPC) Q3 2022 Earnings Call Transcript
- iSpecimen Inc. (NASDAQ:ISPC ) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Allison Soss - IR Tracy Curley - Interim-CEO and CFO Conference Call Participants Matt Hewitt - Craig-Hallum Capital Operator Good day, everyone, and welcome to the iSpecimen Third Quarter 2022 Conference Call. [Operator Instructions] This conference call is being recorded.
- 11/08/2022
|
iSpecimen to Report Third Quarter 2022 Results on November 8, 2022
- LEXINGTON, Mass., Oct. 25, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the third quarter ended September 30, 2022, before the markets open on Tuesday, November 8, 2022.
- 10/25/2022
|
iSpecimen to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022
- LEXINGTON, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate in the H.C. Wainwright 24th Annual Global Investment Conference to be held at the Lotte New York Palace Hotel in New York City on September 12-14, 2022.
- 08/31/2022
|
iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q2 2022 Results - Earnings Call Transcript
- iSpecimen Inc. (NASDAQ:ISPC ) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Allison Soss - Senior Vice President of Investor Relations Christopher Ianelli - President & Chief Executive Officer Jill Mullan - Chief Operating Officer Tracy Curley - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Constantine Davides - EF Hutton James Lieberman - Revere Securities Operator Good day, everyone and welcome to iSpecimen Second Quarter 2022 Conference Call. [Operator Instructions] A replay of today's call will be available on the Investor Relations section of iSpecimen's website and will remain posted there for the next 30 days.
- 08/08/2022
|
iSpecimen to Report Second Quarter 2022 Results on August 4, 2022
- LEXINGTON, Mass., July 21, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the second quarter ended June 30, 2022, before the markets open on Thursday, August 4, 2022.
- 07/21/2022
|
Why iSpecimen Shares Are Gaining Today?
- iSpecimen Inc (NASDAQ: ISPC) has added new global biospecimen suppliers to its proprietary Marketplace platform for advancing oncology and cardiovascular disease research. The new suppliers include a cancer-focused biobank in the U.S., which contains a differentiated range of pre-.
- 07/07/2022
|
iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q1 2022 Results - Earnings Call Transcript
- iSpecimen Inc. (NASDAQ:ISPC ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Allison Soss - Investor Relations Christopher Ianelli - Chief Executive Officer and President Tracy Curley - Chief Financial Officer Jill Mullan - Chief Operating Officer Conference Call Participants Matthew Hewitt - Craig-Hallum Capital Group Constantine Davides - EF Hutton Operator Good day, everyone, and welcome to iSpecimen's First Quarter 2022 Conference Call. [Operator Instructions] This conference is being recorded.
- 05/14/2022
|
iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q4 2021 Results - Earnings Call Transcript
- iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q4 2021 Results - Earnings Call Transcript
- 02/17/2022
|
iSpecimen to Participate in the Aegis Virtual Conference on February 24, 2022
- LEXINGTON, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”), an online marketplace for human biospecimens, today announced that Christopher Ianelli, MD, PhD, CEO and President, will participate in the Aegis Capital Corp. Virtual Conference to be held virtually on February 23-25, 2022.
- 02/10/2022
|
iSpecimen to Report Fourth Quarter and Full Year 2021 Results on February 17, 2022
- LEXINGTON, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”), an online marketplace for human biospecimens, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2021, before the markets open on Thursday, February 17, 2022.
- 02/03/2022
|
iSpecimen Stock (ISPC): Why The Price Went Up Today
- The stock price of iSpecimen Inc (NASDAQ: ISPC) increased by over 4% during intraday trading today. This is why it happened.
- 01/13/2022
|
Why ISpecimen Shares Are Surging Higher Today
- ISpecimen Inc (NASDAQ: ISPC) is trading higher Thursday after the company announced the addition of a reference lab in New York to support commercial and government customers focused on COVID-19 research. ISpecimen said the reference lab has the capacity to sequence hundreds of COVID-19 positive swabs per week.
- 01/13/2022
|
ISPC Stock: What Is Going on With Little-Known iSpecimen Today?
- ISPC stock received a $20 price target from Craig-Hallum today. This comes after iSpecimen made several developments during 2021.
- 01/04/2022
|
See why Craig-Hallum Is Bullish On iSpecimen
- Craig-Hallum initiated coverage of iSpecimen Inc (NASDAQ:ISPC) with a Buy rating and $20 price target. "Much the way Amazon has become the go-to platform for buyers and sellers of consumer goods," the analyst believes iSpecimen can become the go-to platform for human biospecimens, writes analyst Matthew Hewitt.
- 01/04/2022
|
5 Short Squeeze Candidates To Watch: Petros Pharmaceuticals, iSpecimen Top The List Again
- Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge movie. GameStop Corp (NYSE:GME) and AMC Entertainment Holdings (NYSE:AMC) are two high-profile examples of short squeezes earlier this year.
- 12/20/2021
|
iSpecimen (ISPC) Stock: Why The Price Increased Today
- The stock price of iSpecimen Inc (NASDAQ: ISPC) increased by over 7% pre-market today. This is why it happened.
- 11/30/2021
|
iSpecimen (ISPC) Stock: Why The Price Fell Today
- The stock price of iSpecimen Inc (NASDAQ: ISPC) fell by over 6% pre-market today. This is why it happened.
- 11/29/2021
|
iSpecimen (ISPC) Stock: Why The Price Surged Today
- The stock price of iSpecimen Inc (NASDAQ: ISPC) increased by over 65% pre-market today. This is why it happened.
- 11/26/2021
|
Here is why iSpecimen is up 50% today
- iSpecimen Inc (NASDAQ: ISPC) is a human biospecimens marketplace that operates online. It announced that private companies and the U.S government had contracted it to be a part of the new advanced Covid-19 research efforts providing the process with human biospecimens.
- 11/23/2021
|
Why ISpecimen Shares Continue To Move Higher Today
- ISpecimen Inc (NASDAQ: ISPC) is trading higher Tuesday on continued upward momentum after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes and testing validity among multiple population segments. ISpecimen's work on COVID-19 began immediately after the outbreak last year when it began helping researchers monitor antibody development for possible guidance on immunity.
- 11/23/2021
|
iSpecimen (ISPC) Stock: Why The Price Surged Today
- The stock price of iSpecimen Inc. (NASDAQ: ISPC) increased by over 85% pre-market today. This is why it happened.
- 11/23/2021
|
3 Hot Penny Stocks to Watch That Exploded Today, One Up 93%
- Why these three penny stocks exploded today The post 3 Hot Penny Stocks to Watch That Exploded Today, One Up 93% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 11/22/2021
|
PRFX Stock: 8 Things to Know About PainReform as Shares Trend on Unusually Heavy Volume Today
- PainReform (PRFX) stock is on the move Monday with heavy trading despite a lack of news coming from the medical device company. The post PRFX Stock: 8 Things to Know About PainReform as Shares Trend on Unusually Heavy Volume Today appeared first on InvestorPlace.
- 11/22/2021
|
ISPC Stock: The Covid-19 Research News That Has iSpecimen Shares Skyrocketing 100% Today
- iSpecimen (ISPC) stock is up Monday after announcing partnerships with the U.S. Government and private researchers for Covid-19 research. The post ISPC Stock: The Covid-19 Research News That Has iSpecimen Shares Skyrocketing 100% Today appeared first on InvestorPlace.
- 11/22/2021
|
iSpecimen Stock Rallies On Supply Pact Of Human Biospecimens For COVID-19 Research
- iSpecimen Inc (NASDAQ: ISPC), an online marketplace for human biospecimens, has been contracted to support new advanced research on COVID-19. In the last ten months, the Company has partnered with multiple research and health care organizations on diverse projects requiring a variety of COVID-19 samples, including nasal swabs, saliva, and blood products.
- 11/22/2021
|
iSpecimen (ISPC) Stock: Why The Price Surged Today
- The stock price of iSpecimen Inc (NASDAQ: ISPC) increased by over 135% pre-market today. This is why it happened.
- 11/22/2021
|
iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q3 2021 Results - Earnings Call Transcript
- iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q3 2021 Results - Earnings Call Transcript
- 11/06/2021
|
iSpecimen to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference on September 13-15, 2021
- LEXINGTON, Mass., Sept. 1, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate in the H.C.
- 09/01/2021
|
iSpecimen Expands Human Biospecimen Offerings for Cancer Researchers
- LEXINGTON, Mass., Aug. 18, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC), an online marketplace for human biospecimens ("iSpecimen" or the "Company"), today announced it has grown its cancer-related supplier network despite lockdowns, slowdowns, and sustained concern around the COVID-19 pandemic.
- 08/18/2021
|
iSpecimen Inc. Interview to Air on the RedChip Money Report® on Bloomberg TV
- LEXINGTON, Mass., Aug. 12, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC), an online marketplace for human biospecimens ("iSpecimen" or the "Company"), today announced that an interview with its CEO and President, Dr. Christopher Ianelli, will air on The RedChip Money Report® on Bloomberg TV, at 7 p.m.
- 08/12/2021
|
iSpecimen Reports Second Quarter 2021 Financial Results
- LEXINGTON, Mass., Aug. 10, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today reported its financial results for the three-month period ended June 30, 2021.
- 08/10/2021
|
iSpecimen Launches Enhanced Custom Collection Service
- LEXINGTON, Mass., July 29, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC), an online marketplace for human biospecimens ("iSpecimen" or the "Company"), today announced that it has enhanced its custom biofluids collection service to offer life sciences organizations faster delivery of urgently needed research samples.
- 07/29/2021
|
iSpecimen to Report Second Quarter 2021 Results on August 10, 2021
- LEXINGTON, Mass., July 27, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that it will report its financial results for the second quarter ended June 30, 2021, before the market open on Tuesday, August 10, 2021.
- 07/27/2021
|
iSpecimen: High Growth Marketplace At A Discount
- iSpecimen: High Growth Marketplace At A Discount
- 07/07/2021
|
iSpecimen Announces Closing of Over-Allotment Option in Connection with its Initial Public Offering
- LEXINGTON, Mass., July 1, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced the closing of the issuance of an additional 337,500 shares of its common stock pursuant to the full exercise of the underwriters' over-allotment option in connection with the Company's initial public offering (the "IPO").
- 07/01/2021
|
iSpecimen Announces Closing of Initial Public Offering
- LEXINGTON, Mass., June 21, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced the closing of its previously announced initial public offering of 2,250,000 shares of its common stock at a price of $8.00 per share, for gross proceeds of $18,000,000 before deducting underwriting discounts, commissions and offering expenses.
- 06/21/2021
|
3 Biotechs Plus a Mortgage Lender Go Public Today
- The companies are Verve Therapeutics, Lyell Immunopharma, iSpecimen and Angel Oak Mortgage.
- 06/17/2021
|
